Type I and III Interferon Productions Are Impaired in X-Linked Agammaglobulinemia Patients Toward Poliovirus but Not Influenza Virus

Background X-linked agammaglobulinemia (XLA) is a primary immunodeficiency caused by Bruton’s tyrosine kinase (BTK) mutation. Patients are susceptible to severe enterovirus infections. The underlying mechanism remains unknown. BTK is involved in toll-like receptors pathway, which initiates antiviral responses including interferon (IFN) productions. Objective To demonstrate type I and III IFN productions in dendritic cells of XLA patients is decreased in response to oral poliovirus vaccine (OPV) but not H1N1 virus. Methods Monocyte-derived dendritic cells (MoDCs) were derived from nine XLA patients aged 22–32 years old and 23 buffy coats from Hong Kong Red Cross blood donors. LFM-A13 was used to inhibit BTK. OPV Sabin type 1 and H1N1 influenza virus were used to stimulate MoDCs with RPMI as mock stimulation. The antiviral cytokine productions and phenotypic maturation of MoDCs were determined 24 h post-stimulation. OPV RNA was determined at 0, 6, 12, and 24 h post-stimulation. Results Upon OPV stimulation, IFN-α2, IFN-β, and IFN-λ1 productions in MoDCs from XLA patients and BTK-inhibited MoDCs of healthy controls were significantly lower than that from healthy controls. Whereas upon H1N1 stimulation, the IFN-α2, IFN-β, and IFN-λ1 productions were similar in MoDCs from XLA patients, BTK-inhibited MoDCs of healthy controls and healthy controls. The mean fluorescent intensities (MFI) of CD83, CD86, and MHC-II in MoDCs from XLA patients in response to OPV was similar to that in response to mock stimulation, while the MFI of CD83, CD86, and MHC-II were significantly higher in response to H1N1 stimulation than that in response to mock stimulation. Whereas, the MFI of CD83, CD86, and MHC-II in MoDCs of healthy controls were significantly higher in response to both OPV and H1N1 stimulation compared to that in response to mock stimulation. Conclusion Production of type I and III IFN in response to OPV was deficient in MoDCs from XLA patients, but was normal in response to H1N1 due to deficient BTK function. Moreover, phenotypic maturation of MoDCs from XLA patients was impaired in response to OPV but not to H1N1. These selective impairments may account for the unique susceptibility of XLA patients toward severe enterovirus infections.

[1]  Fernando Villalón-Letelier,et al.  Host Cell Restriction Factors that Limit Influenza A Infection , 2017, Viruses.

[2]  A. Weber,et al.  Bruton’s Tyrosine Kinase: An Emerging Key Player in Innate Immunity , 2017, Front. Immunol..

[3]  S. Gilmour,et al.  Prolonged Excretion of Poliovirus among Individuals with Primary Immunodeficiency Disorder: An Analysis of the World Health Organization Registry , 2017, Front. Immunol..

[4]  J. Franco,et al.  Patients with Primary Immunodeficiencies Are a Reservoir of Poliovirus and a Risk to Polio Eradication , 2017, Front. Immunol..

[5]  N. Stevenson,et al.  Advances in anti-viral immune defence: revealing the importance of the IFN JAK/STAT pathway , 2017, Cellular and Molecular Life Sciences.

[6]  L. Krilov,et al.  Enterovirus Infections , 2016, Pediatrics in Review.

[7]  K. Schughart,et al.  Deletion of Irf3 and Irf7 Genes in Mice Results in Altered Interferon Pathway Activation and Granulocyte-Dominated Inflammatory Responses to Influenza A Infection , 2016, Journal of Innate Immunity.

[8]  B. Knebelmann,et al.  Case report and literature review , 2016, Medicine.

[9]  Zheng Xing,et al.  Differential Regulation of TLR Signaling on the Induction of Antiviral Interferons in Human Intestinal Epithelial Cells Infected with Enterovirus 71 , 2016, PloS one.

[10]  Surjit Singh,et al.  X-linked Agammaglobulinemia , 2016, The Indian Journal of Pediatrics.

[11]  K. Strebhardt,et al.  The role of Plk3 in oncogenesis , 2016, Oncogene.

[12]  Jianwei Wang,et al.  Innate Immunity Evasion by Enteroviruses: Insights into Virus-Host Interaction , 2016, Viruses.

[13]  Wenbo Xu,et al.  An Insight into Recombination with Enterovirus Species C and Nucleotide G-480 Reversion from the Viewpoint of Neurovirulence of Vaccine-Derived Polioviruses , 2015, Scientific Reports.

[14]  C. Cunningham-Rundles,et al.  Toll‐like receptor signaling in primary immune deficiencies , 2015, Annals of the New York Academy of Sciences.

[15]  R. Hartmann,et al.  Guarding the frontiers: the biology of type III interferons , 2015, Nature Immunology.

[16]  B. Sukumaran,et al.  Bruton's tyrosine kinase phosphorylates DDX41 and activates its binding of dsDNA and STING to initiate type 1 interferon response. , 2015, Cell reports.

[17]  A. Sher,et al.  Type I interferons in infectious disease , 2015, Nature Reviews Immunology.

[18]  R. Sutter,et al.  Vaccine-associated paralytic poliomyelitis: a review of the epidemiology and estimation of the global burden. , 2014, The Journal of infectious diseases.

[19]  Koon-Guan Lee,et al.  Bruton's Tyrosine Kinase and Protein Kinase C µ Are Required for TLR7/9-Induced IKKα and IRF-1 Activation and Interferon-β Production in Conventional Dendritic Cells , 2014, PloS one.

[20]  V. Lougaris,et al.  Bruton tyrosine kinase mediates TLR9-dependent human dendritic cell activation. , 2014, The Journal of allergy and clinical immunology.

[21]  Akiko Iwasaki,et al.  Innate immunity to influenza virus infection , 2014, Nature Reviews Immunology.

[22]  P. Ravindran,et al.  Bruton's tyrosine kinase regulates TLR9 but not TLR7 signaling in human plasmacytoid dendritic cells , 2014, European journal of immunology.

[23]  Steven H Kleinstein,et al.  Dynamic expression profiling of type I and type III interferon‐stimulated hepatocytes reveals a stable hierarchy of gene expression , 2014, Hepatology.

[24]  C. Rice,et al.  Interferon-stimulated genes: a complex web of host defenses. , 2014, Annual review of immunology.

[25]  Cheng Luo,et al.  K63-linked polyubiquitination of transcription factor IRF1 is essential for IL-1-induced production of chemokines CXCL10 and CCL5 , 2014, Nature Immunology.

[26]  R. Steinman,et al.  Direct Type I IFN but Not MDA5/TLR3 Activation of Dendritic Cells Is Required for Maturation and Metabolic Shift to Glycolysis after Poly IC Stimulation , 2014, PLoS biology.

[27]  C. Coyne,et al.  Enter at your own risk: how enteroviruses navigate the dangerous world of pattern recognition receptor signaling. , 2013, Cytokine.

[28]  Yamei Chen,et al.  Ibrutinib and novel BTK inhibitors in clinical development , 2013, Journal of Hematology & Oncology.

[29]  J. Deshpande,et al.  Differential induction of Toll-like receptors & type 1 interferons by Sabin attenuated & wild type 1 polioviruses in human neuronal cells , 2013, The Indian journal of medical research.

[30]  B. Corthésy,et al.  Multi-Faceted Functions of Secretory IgA at Mucosal Surfaces , 2013, Front. Immunol..

[31]  W. Thomas,et al.  Bruton's Tyrosine Kinase Is Required for Apoptotic Cell Uptake via Regulating the Phosphorylation and Localization of Calreticulin , 2013, The Journal of Immunology.

[32]  K. Kuchler,et al.  The Tyrosine Kinase Btk Regulates the Macrophage Response to Listeria monocytogenes Infection , 2013, PloS one.

[33]  T. Michiels,et al.  Antiviral Type I and Type III Interferon Responses in the Central Nervous System , 2013, Viruses.

[34]  A. Dotzauer,et al.  Innate and adaptive immune responses against picornaviruses and their counteractions: An overview. , 2012, World journal of virology.

[35]  L. Santos‐Argumedo,et al.  Increased Pro-inflammatory Cytokine Production After Lipopolysaccharide Stimulation in Patients with X-linked Agammaglobulinemia , 2012, Journal of Clinical Immunology.

[36]  Y. Lau,et al.  Tyrosine Kinase Btk Is Required for NK Cell Activation , 2012, The Journal of Biological Chemistry.

[37]  S. Akira,et al.  Bruton's tyrosine kinase phosphorylates Toll-like receptor 3 to initiate antiviral response , 2012, Proceedings of the National Academy of Sciences.

[38]  A. Kissenpfennig,et al.  Defects in acute responses to TLR4 in Btk-deficient mice result in impaired dendritic cell-induced IFN-γ production by natural killer cells. , 2012, Clinical immunology.

[39]  C. Cunningham-Rundles,et al.  Toll-like receptor 4-, 7-, and 8-activated myeloid cells from patients with X-linked agammaglobulinemia produce enhanced inflammatory cytokines. , 2012, The Journal of allergy and clinical immunology.

[40]  Y. Lau,et al.  Dendritic and T Cell Response to Influenza is Normal in the Patients with X-Linked Agammaglobulinemia , 2012, Journal of Clinical Immunology.

[41]  Jacob T. Robinson,et al.  Systematic Discovery of TLR Signaling Components Delineates Viral-Sensing Circuits , 2011, Cell.

[42]  S. Akira,et al.  The Toll-Like Receptor 3-Mediated Antiviral Response Is Important for Protection against Poliovirus Infection in Poliovirus Receptor Transgenic Mice , 2011, Journal of Virology.

[43]  Mingli Liu,et al.  The emerging role of CXCL10 in cancer (Review). , 2011, Oncology letters.

[44]  P. Zhang,et al.  Intracellular MHC class II molecules promote TLR-triggered innate immune responses by maintaining activation of the kinase Btk , 2011, Nature Immunology.

[45]  R. Feuer,et al.  Enterovirus infections of the central nervous system , 2011, Virology.

[46]  E. Wong,et al.  Bruton's Tyrosine Kinase Separately Regulates NFκB p65RelA Activation and Cytokine Interleukin (IL)-10/IL-12 Production in TLR9-stimulated B Cells* , 2008, Journal of Biological Chemistry.

[47]  C. Figdor,et al.  Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration , 2008, Cancer Immunology, Immunotherapy.

[48]  A. Salavati,et al.  Novel BTK mutation presenting with vaccine-associated paralytic poliomyelitis , 2008, European Journal of Pediatrics.

[49]  H. Kanegane,et al.  Toll-like receptor signaling is impaired in dendritic cells from patients with X-linked agammaglobulinemia. , 2008, Clinical immunology.

[50]  C. Feighery,et al.  Signaling by Toll-like Receptors 8 and 9 Requires Bruton's Tyrosine Kinase* , 2007, Journal of Biological Chemistry.

[51]  J. Casanova,et al.  Human Toll‐like receptor‐dependent induction of interferons in protective immunity to viruses , 2007, Immunological reviews.

[52]  Shohei Koyama,et al.  Differential Role of TLR- and RLR-Signaling in the Immune Responses to Influenza A Virus Infection and Vaccination , 2007, The Journal of Immunology.

[53]  A. Šedivá,et al.  Impaired Toll-like receptor 8-mediated IL-6 and TNF-alpha production in antigen-presenting cells from patients with X-linked agammaglobulinemia. , 2007, Blood.

[54]  A. Coutinho,et al.  Immunity to Microbes: Lessons from Primary Immunodeficiencies , 2007, Infection and Immunity.

[55]  F. Uckun,et al.  Anti-breast cancer activity of LFM-A13, a potent inhibitor of Polo-like kinase (PLK). , 2007, Bioorganic & medicinal chemistry.

[56]  P. Mahadevan,et al.  An overview , 2007, Journal of Biosciences.

[57]  M. Kaplan,et al.  Bruton’s Tyrosine Kinase Is Required for TLR-Induced IL-10 Production1 , 2006, The Journal of Immunology.

[58]  J. Casanova,et al.  Herpes Simplex Virus Encephalitis in Human UNC-93B Deficiency , 2006, Science.

[59]  K. Honda,et al.  Type I Inteferon Gene Induction by the Interferon Regulatory Factor Family of Transcription Factors , 2006 .

[60]  E. López-Granados,et al.  Bruton's tyrosine kinase is not essential for LPS-induced activation of human monocytes. , 2006, The Journal of allergy and clinical immunology.

[61]  F. Brennan,et al.  Bruton’s Tyrosine Kinase Is Required for TLR2 and TLR4-Induced TNF, but Not IL-6, Production1 , 2006, The Journal of Immunology.

[62]  C. Cunningham-Rundles,et al.  TLR9 Activation Is Defective in Common Variable Immune Deficiency1 , 2006, The Journal of Immunology.

[63]  Keiko Ozato,et al.  IRF family proteins and type I interferon induction in dendritic cells , 2006, Cell Research.

[64]  K. Früh,et al.  Interferon Regulatory Factor 3 Is Necessary for Induction of Antiviral Genes during Human Cytomegalovirus Infection , 2006, Journal of Virology.

[65]  V. Racaniello.  One hundred years of poliovirus pathogenesis. , 2006, Virology.

[66]  O. Berthier‐Vergnes,et al.  TNF‐α enhances phenotypic and functional maturation of human epidermal Langerhans cells and induces IL‐12 p40 and IP‐10/CXCL‐10 production , 2005, FEBS letters.

[67]  M. Chow,et al.  Virus-Specific CD4+ and CD8+ Cytotoxic T-Cell Responses and Long-Term T-Cell Memory in Individuals Vaccinated against Polio , 2005, Journal of Virology.

[68]  H. Yonekawa,et al.  The Alpha/Beta Interferon Response Controls Tissue Tropism and Pathogenicity of Poliovirus , 2005, Journal of Virology.

[69]  A. R.,et al.  Review of literature , 1951, American Potato Journal.

[70]  E. Moxon,et al.  Chronic enteroviral meningoencephalitis in agammaglobulinemia: Case report and literature review , 1992, Journal of Clinical Immunology.

[71]  J. Dai,et al.  Comparative analysis of IRF and IFN‐alpha expression in human plasmacytoid and monocyte‐derived dendritic cells , 2003, Journal of leukocyte biology.

[72]  T. Wirth,et al.  Bruton's Tyrosine Kinase Is a Toll/Interleukin-1 Receptor Domain-binding Protein That Participates in Nuclear Factor κB Activation by Toll-like Receptor 4* , 2003, Journal of Biological Chemistry.

[73]  C. Cancrini,et al.  Bruton's tyrosine kinase defect in dendritic cells from X‐linked agammaglobulinaemia patients does not influence their differentiation, maturation and antigen‐presenting cell function , 2003, Clinical and experimental immunology.

[74]  H. Mano,et al.  Bruton's Tyrosine Kinase Is Required For Lipopolysaccharide-induced Tumor Necrosis Factor α Production , 2003, The Journal of experimental medicine.

[75]  M. Ferrantini,et al.  IFN‐α2a induces IP‐10/CXCL10 and MIG/CXCL9 production in monocyte‐derived dendritic cells and enhances their capacity to attract and stimulate CD8+ effector T cells , 2002, Journal of Leukocyte Biology.

[76]  D. Levy,et al.  Enhancement and diversification of IFN induction by IRF-7-mediated positive feedback. , 2002, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[77]  J. Casanova,et al.  Enteroviral meningoencephalitis in X-linked agammaglobulinemia: intensive immunoglobulin therapy and sequential viral detection in cerebrospinal fluid by polymerase chain reaction. , 2000, The Pediatric infectious disease journal.

[78]  K. Matsushima,et al.  TNF-α IS A POTENT INDUCER FOR IFN-INDUCIBLE PROTEIN-10 IN HEPATOCYTES AND UNAFFECTED BY GM-CSF IN VIVO, IN CONTRAST TO IL-1β AND IFN-γ , 2000 .

[79]  M. Pallansch,et al.  Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: a review of the literature. , 1997, The Journal of infectious diseases.

[80]  K. Eberle,et al.  Correlation between poliovirus type 1 Mahoney replication in blood cells and neurovirulence , 1996, Journal of virology.

[81]  J. V. van Dongen,et al.  The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages , 1993, European journal of immunology.

[82]  T. Hahn,et al.  Interferon deficiency syndrome. , 1985, Clinical and experimental immunology.

[83]  H. Wyatt.  Poliomyelitis in hypogammaglobulinemics. , 1973, The Journal of infectious diseases.